Literature DB >> 3184174

Effects of pH, potential, chloride and furosemide on passive Na+ and K+ effluxes from human red blood cells.

A M Zade-Oppen1, N C Adragna, D C Tosteson.   

Abstract

Ouabain-resistant effluxes from pretreated cells containing K+/Na+ = 1.5 into K+ and Na+ free media were measured. Furosemide-sensitive cation effluxes from cells with nearly normal membrane potential and pH were lower in NO3- media than in Cl- media; they were reduced when pH was lowered in Cl- media. When the membrane potential was positive inside furosemide increased the effluxes of Na+ and K+ (7 experiments). With inside-positive membrane potential the furosemide-insensitive effluxes were markedly increased, they decreased with decreasing pH at constant internal Cl- and also when internal Cl- was reduced at constant pH. The correlation between cation flux and the membrane potential was different for cells with high or low internal chloride concentrations. The data with chloride greater than or equal to 47 mM showed a better fit with the single-barrier model than with the infinite number-of-barriers model. With low chloride no significant correlation between flux and membrane potential was found. The data are not compatible with pure independent diffusion of Na+ and K+ in the presence of ouabain and furosemide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3184174     DOI: 10.1007/bf01993981

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  26 in total

1.  The cation permeability of erythrocytes in low ionic strength media of various tonicities.

Authors:  J A Donlon; A Rothstein
Journal:  J Membr Biol       Date:  1969-12       Impact factor: 1.843

2.  Chloride and water distribution in human red cells.

Authors:  M Dalmark
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

3.  Equilibrium dialysis of ions in nystatin-treated red cells.

Authors:  A Cass; M Dalmark
Journal:  Nat New Biol       Date:  1973-07-11

4.  An effect of chloride on (Na+K) co-transport in human red blood cells.

Authors:  A R Chipperfield
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

5.  Amiloride stimulation of sodium transport in the presence of calcium and a divalent cation chelator.

Authors:  C L Thurman; J T Higgins
Journal:  Biochim Biophys Acta       Date:  1982-08-12

6.  Increased sodium-lithium countertransport in red cells of patients with essential hypertension.

Authors:  M Canessa; N Adragna; H S Solomon; T M Connolly; D C Tosteson
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

7.  Outward sodium and potassium cotransport in human red cells.

Authors:  R Garay; N Adragna; M Canessa; D Tosteson
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

8.  Ouabain-insensitive sodium movements in the human red blood cell.

Authors:  J R Sachs
Journal:  J Gen Physiol       Date:  1971-03       Impact factor: 4.086

9.  Modes of operation and variable stoichiometry of the furosemide- sensitive Na and K fluxes in human red cells.

Authors:  M Canessa; C Brugnara; D Cusi; D C Tosteson
Journal:  J Gen Physiol       Date:  1986-01       Impact factor: 4.086

10.  The kinetics of ouabain inhibition and the partition of rubidium influx in human red blood cells.

Authors:  L A Beauge; N Adragna
Journal:  J Gen Physiol       Date:  1971-05       Impact factor: 4.086

View more
  3 in total

1.  Carrier-mediated residual K+ and Na+ transport of human red blood cells.

Authors:  K Denner; R Heinrich; I Bernhardt
Journal:  J Membr Biol       Date:  1993-03       Impact factor: 1.843

2.  Activation of a novel organic solute transporter in mammalian red blood cells.

Authors:  S J Culliford; I Bernhardt; J C Ellory
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

3.  Effects of low ionic strength media on passive human red cell monovalent cation transport.

Authors:  I Bernhardt; A C Hall; J C Ellory
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.